Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Pediatric Blood & Cancer|July 28, 2023
Children's Oncology Group's 2023 blueprint for research: Bone tumorsDamon R Reed, Patrick Grohar, Elyssa Rubin, et al.
Pediatric Blood & Cancer|October 27, 2004
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experiencePatrick Van Winkle, Anne Angiolillo, Mark Krailo, et al.
Pediatric Blood & Cancer|January 23, 2015
A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW FoundationJason Glover, Mark Krailo, Tanya Tello, et al.
Epigenetics|December 23, 2014
Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse statusJeremy M Rosenblum, N Ari Wijetunga, Melissa J Fazzari, et al.
Cancer Letters|June 9, 2006
Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology GroupYinghao Su, Stella Davies, Mary Davis, et al.
Sarcoma|October 29, 2015
Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group ReportNeyssa Marina, Linda Granowetter, Holcombe E Grier, et al.
Pediatric Blood & Cancer|April 27, 2018
Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 studyFarzana Pashankar, A Lindsay Frazier, Mark Krailo, et al.
Cancer|March 15, 2006
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology GroupTed Zwerdling, Mark Krailo, Philip Monteleone, et al.
Pediatric Blood & Cancer|January 26, 2006
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group studyDouglas S Hawkins, Scott Bradfield, James A Whitlock, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group StudyLisa R Bomgaars, Mark Bernstein, Mark Krailo, et al.
Pediatric Blood & Cancer|July 28, 2023
Children's Oncology Group's 2023 blueprint for research: Bone tumorsDamon R Reed, Patrick Grohar, Elyssa Rubin, et al.
Pediatric Blood & Cancer|October 27, 2004
Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experiencePatrick Van Winkle, Anne Angiolillo, Mark Krailo, et al.
Pediatric Blood & Cancer|January 23, 2015
A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW FoundationJason Glover, Mark Krailo, Tanya Tello, et al.
Epigenetics|December 23, 2014
Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse statusJeremy M Rosenblum, N Ari Wijetunga, Melissa J Fazzari, et al.
Cancer Letters|June 9, 2006
Expression of LINE-1 p40 protein in pediatric malignant germ cell tumors and its association with clinicopathological parameters: a report from the Children's Oncology GroupYinghao Su, Stella Davies, Mary Davis, et al.
Sarcoma|October 29, 2015
Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group ReportNeyssa Marina, Linda Granowetter, Holcombe E Grier, et al.
Pediatric Blood & Cancer|April 27, 2018
Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 studyFarzana Pashankar, A Lindsay Frazier, Mark Krailo, et al.
Cancer|March 15, 2006
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology GroupTed Zwerdling, Mark Krailo, Philip Monteleone, et al.
Pediatric Blood & Cancer|January 26, 2006
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group studyDouglas S Hawkins, Scott Bradfield, James A Whitlock, et al.
Pageof 17